Gemcitabine trials for Stage III Pancreatic Cancer AJCC v8

All Gemcitabine trials · All Stage III Pancreatic Cancer AJCC v8 trials

Phase breakdown

Recruiting trials studying Gemcitabine for Stage III Pancreatic Cancer AJCC v8

• AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
  NCT07619313 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
  NCT06454383 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
  NCT06423326 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
  NCT06998940 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 274 locations
• Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
  NCT06958328 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 322 locations

Common questions

How many trials study Gemcitabine for Stage III Pancreatic Cancer AJCC v8?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.